Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ: FTRE )

16.82 -0.33 (-1.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 Next >
Fortrea Releases Inaugural Corporate Social Responsibility Report
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
FTRE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fortrea Holdings Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Fortrea Reports Second Quarter 2024 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Appoints Robert Parks as Chief Accounting Officer
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Jefferies Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Appoints Machelle Sanders to Board of Directors
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports First Quarter 2024 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
Companies partner to provide patients and sites with easy access to study information in one integrated solution 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Previews J.P. Morgan Healthcare Conference Updates
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Convenes New Site Advisory Board
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies 
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Reports Third Quarter 2023 Results
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers 
From Fortrea Holdings Inc
Via GlobeNewswire
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit
From Starboard Value LP
Via Business Wire
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access 
From Fortrea Holdings Inc
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.